Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial ATP synthase is a multi-subunit enzyme complex responsible for synthesizing adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic phosphate (Pi), utilizing the energy derived from a transmembrane proton motive force. This enzyme is essential for cellular energy production in bacteria. It consists of two main regions: the membrane-embedded F₀ region, which forms the proton channel, and the hydrophilic F₁ region, which protrudes into the cytoplasm and contains the catalytic sites for ATP synthesis/hydrolysis. Protons flow through the F₀ portion, driving rotation that induces conformational changes in F₁’s catalytic sites, enabling ATP synthesis. Bacterial ATP synthases are targets for novel antibiotics due to structural differences compared to mammalian ATP synthases.
Inhibition of ATP synthesis by blocking proton flow or rotary motion of the enzyme
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial ATP Synthase (ATP Synthase).